Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists

Details for Australian Patent Application No. 2005214376 (hide)

Owner AstraZeneca AB NPS Pharmaceuticals, Inc.

Inventors Isaac, Methvin; Bryan, Chris; Stefanac, Tomislav

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005214376

PCT Pub. Number WO2005/080363

Priority 60/545,290 18.02.04 US

Filing date 17 February 2005

Wipo publication date 1 September 2005

International Classifications

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 295/073 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 295/205 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/10 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

31 August 2006 PCT application entered the National Phase

  PCT publication WO2005/080363 Priority application(s): WO2005/080363

13 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214378-Polyheterocyclic compounds and their use as metabotropic glutamate receptor antagonists

2005214375-Triazole compounds and their use as metabotropic glutamate receptor antagonists